Approvals/TGA/DOPRILAMIDE 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate 1.25mg tablets blister pack

Approved

STANDARD

DOPRILAMIDE 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate 1.25mg tablets blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 1732af6f30c23b7b
Product Name: DOPRILAMIDE 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate 1.25mg tablets blister pack
Artg Id: 132339
Artg Name: DOPRILAMIDE 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate 1.25mg tablets blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2007-11-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

1732af6f30c23b7b

Type

Standard